IL1B and irritable bowel syndrome: Eight markers, i.e. plasma IL-1β, IL-6, IL-12p70, and fecal CgA, calprotectin, HBD2, valerate, and caproate, proved to be significantly altered in IBS patients compared to HC, when tested by univariate analyses (Table 2).